Jails Face Medetomidine-Laced Opioid Withdrawal Crisis Without Treatment Protocols
Correctional facilities are increasingly encountering severe withdrawal cases from opioids contaminated with medetomidine, a veterinary sedative, but lack established treatment protocols for this emerging threat. The drug causes life-threatening withdrawal symptoms distinct from traditional opioid withdrawal, including extreme cardiovascular instability. Jails serve as unintentional frontline medical facilities as individuals enter custody experiencing these dangerous withdrawal episodes. Many facilities remain unprepared with limited access to specialized medical staff or evidence-based treatment approaches for this substance combination.
Medicaid managed care organizations will face coverage and care coordination obligations for justice-involved individuals experiencing medetomidine-complicated withdrawal upon community reentry, requiring protocols for addressing non-standard substance use disorders and potential high-acuity medical needs.
Behavioral Health · Managed Care
You might also like